January 27, 2016 – CHARLOTTESVILLE, Va. BrightSpec, Inc. announced the delivery and installation of its Chiral FT-MRR Broadband microwave spectrometer at the Universidad de Valladolid in Valladolid, Spain. The BrightSpec Chiral Fourier Transform-Molecular Rotational Resonance (FT-MRR) Broadband spectrometer enables researchers to perform a wide range of molecular analyses directly on complex chemical mixtures. The Chiral FT-MRR system is designed as a standalone instrument to identify enantiomers and measure enantiomeric excess, as well as perform the full range of microwave spectroscopy measurements traditionally done by investigative researchers. This delivery marks the first BrightSpec chiral FT-MRR instrument sale.
The instrument will be available at the Laboratory of Instrumental Techniques (LTI-UVa) of the University. The lab offers scientific and technological support to researchers and companies locally and regionally. Researchers at the Universidad de Valladolid have been at the forefront of research in microwave and millimeter-wave spectroscopy for more than 20 years. The installed Chiral FT-MRR microwave spectrometer includes spectral coverage from 0.5 to 8 GHz, and is well suited to studying multi-component mixtures, weakly bound clusters, and chiral molecules.
BrightSpec—the first commercial provider of microwave and millimeter-wave spectrometers—was founded after researchers in the Pate Group at the University of Virginia developed and reduced to practice the Chirped Pulse-Fourier Transform (CP-FT) technique that is the basis of the BrightSpec FT-MRR product platform. The development of CP-FT greatly advanced the field of molecular rotational spectroscopy research, which has been used in academic and government research institutions around the world for more than 60 years. The chiral three-wave mixing technique, discovered in a collaboration between researchers at Harvard University and the Max Plank Institute in Hamburg, was first published in 2013 in a Nature cover article. The patented technique further expands the reach of molecular rotational spectroscopy to the differentiation of enantiomers – molecules that are mirror images of each other, like right- and left-hand gloves. Chirality, or the ‘handedness’ attribute of many molecules plays a fundamental role in the chemistry of life. As a result, the technique opens FT-MRR to a wide range of pharmaceutical drug discovery applications.
About BrightSpec, Inc.
BrightSpec delivers solutions for direct, quantitative mixture analysis for applications in R&D, small molecule drug development, fine chemicals, food, and advanced manufacturing sectors. BrightSpec received research funding from the US Army, the National Science Foundation, and the Virginia BioHealth Research Corp. For more information, please contact Justin Neill (CTO) or Bob Lloyd (CEO) at 434-202-2391, or visit www.brightspec.com.